Market News

Moderna CEO on cancer drug collaboration with Merck

Bloomberg Television4 hours ago1:20

Moderna CEO Stéphane Bancel calls the company’s cancer vaccine study with Merck a “landmark,” pointing to a 42% improvement compared with Keytruda alone. Bancel says Moderna is now focused on filing the drug with the FDA and believes it could be approved next year

Trading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.